Correction
Accepted on 01 Aug 2025
Correction: Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) - a clinical pilot study
in Infectious Diseases: Pathogenesis and Therapy
- 210 views